Literature DB >> 24002401

Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach.

Sarantis Livadas1, Evanthia Diamanti-Kandarakis.   

Abstract

Polycystic ovary syndrome (PCOS) constitutes a continuum spectrum of symptoms starting from the early prepubertal years and continuing after menopause. The phenotypic expression varies through time, depending on several internal (e.g. ovarian/adrenal steroidogenesis, insulin resistance) and external factors (e.g. quality and quantity of food, exercise). Moreover, the emergence of new definitions with the use of ovarian morphology, besides chronic anovulation and hyperandrogenism, as diagnostic criteria, increased the phenotypic variety of PCOS presentation. In this review, the clinician is provided with useful information regarding grey zones in assessing anovulation, hyperandrogenism, ovarian morphology and the difficulties in differential diagnosis of PCOS. Furthermore, the lack of substantial data characterizing metabolic/hormonal profile and the potential cardiovascular risk in newer PCOS phenotypes, as well as the absence of longitudinal data questioning a possible shift from one phenotype to another are underlined. These notions indicate that despite the initial presentation of a patient with PCOS, close follow-up and therapeutic interventions aiming to reduce long-term cardiovascular risk are warranted.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 24002401     DOI: 10.1159/000341673

Source DB:  PubMed          Journal:  Front Horm Res        ISSN: 0301-3073            Impact factor:   2.606


  21 in total

1.  The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome.

Authors:  Monika Sarkar; Norah Terrault; Caroline C Duwaerts; Phyllis Tien; Marcelle I Cedars; Heather Huddleston
Journal:  Curr Opin Gynecol Obstet       Date:  2018-04-05

Review 2.  Targets to treat metabolic syndrome in polycystic ovary syndrome.

Authors:  Shruthi Mahalingaiah; Evanthia Diamanti-Kandarakis
Journal:  Expert Opin Ther Targets       Date:  2015-10-21       Impact factor: 6.902

3.  Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.

Authors:  Thomas S Paterakis; Evanthia Diamanti-Kandarakis
Journal:  Curr Obes Rep       Date:  2014-12

4.  Effect of Electro-acupuncture on Expression of IRS-1/PI3K/GLUT4 Pathway in Ovarian Granulosa Cells of Infertile Patients with Polycystic Ovary Syndrome-Insulin Resistance of Phlegm-Dampness Syndrome.

Authors:  Shan Xiang; Ming-Feng Xia; Jing-Yan Song; Dan-Qi Liu; Fang Lian
Journal:  Chin J Integr Med       Date:  2020-06-22       Impact factor: 1.978

5.  Endocrine and Metabolic Profile of Different Phenotypes of Polycystic Ovarian Syndrome.

Authors:  Saxena Pikee; Singh Shivani; Bhattacharjee Jayshree
Journal:  J Obstet Gynaecol India       Date:  2016-05-04

6.  ANTIMÜLLERIAN HORMONE AS INDICATOR OF OVARIAN DYSFUNCTION.

Authors:  A Bothou; N Koutlaki; G Iatrakis; G Mastorakos; P Tsikouras; V Liberis; G Galazios; A Liberis; A Lykeridou; S Zervoudis
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Apr-Jun       Impact factor: 0.877

Review 7.  The management of patients with polycystic ovary syndrome.

Authors:  Channa N Jayasena; Stephen Franks
Journal:  Nat Rev Endocrinol       Date:  2014-07-15       Impact factor: 43.330

8.  The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis.

Authors:  Tao Ding; Paul J Hardiman; Irene Petersen; Fang-Fang Wang; Fan Qu; Gianluca Baio
Journal:  Oncotarget       Date:  2017-07-12

9.  Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.

Authors:  Dorte Glintborg; Katrine Hass Rubin; Mads Nybo; Bo Abrahamsen; Marianne Andersen
Journal:  Cardiovasc Diabetol       Date:  2018-03-08       Impact factor: 9.951

10.  Liraglutide administration improves hormonal/metabolic profile and reproductive features in women with HAIR-AN syndrome.

Authors:  S Livadas; I Androulakis; N Angelopoulos; A Lytras; F Papagiannopoulos; G Kassi
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.